Clinical Trial: Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277361) titled 'Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment' on Nov. 20.

Brief Summary: Fabry disease is a rare genetic disorder affecting 1 in 10,000 individuals, leading to complications such as chronic pain, heart and kidney failure, and strokes, ultimately impacting life expectancy. People with this disease are increasingly being diagnosed later in life, around the age of 65, as the condition progresses slowly with irreversible organ damage. The effectiveness of treatments for Fabry disease remains controversial, but early initiation is recommended for long-term benefits. Desp...